A 32-year-old woman with community-acquired pneumonia is being treated with either erythromycin or azithromycin. Which pharmacokinetic property best differentiates azithromycin from erythromycin in clinical practice?

Question

Accepted Answer

C. Azithromycin has superior acid stability and requires less frequent dosing due to longer tissue half-life. ## Pharmacokinetic Differentiation: Azithromycin vs Erythromycin

### Clinical Significance of Structural Differences

**Key Point:** The 15-membered lactone ring with methyl-substituted nitrogen in azithromycin confers superior acid stability, allowing reliable oral absorption and once-daily dosing. Erythromycin's 14-membered ring is acid-labile and requires frequent dosing (4 times daily).

### Comparative Pharmacokinetics

| Parameter | Erythromycin | Azithromycin |
|-----------|--------------|---------------|
| Acid stability | Poor (degraded by gastric pH) | Excellent (survives gastric pH) |
| Oral bioavailability | Variable (40–65%) | High and reliable (37–52%) |
| Dosing frequency | 4 times daily (QID) | Once daily (OD) or twice daily |
| Tissue half-life | ~2 hours | 40–68 hours |
| Intracellular penetration | Moderate | Excellent (10–100× higher in macrophages) |
| Protein binding | 70–75% | 50% |
| Metabolism | Hepatic (CYP3A4, CYP1A2) | Hepatic (minor CYP3A4 involvement) |

**High-Yield:** Azithromycin's longer tissue half-life (40–68 hours vs 2 hours for erythromycin) allows:
- Once-daily dosing (improving compliance)
- Post-antibiotic effect (continued bacterial suppression after drug levels fall)
- Shorter total duration of therapy (e.g., 3–5 days vs 10–14 days)

### Clinical Pearl

In respiratory tract infections (pneumonia, bronchitis), azithromycin's superior intracellular penetration and accumulation in lung macrophages and epithelial cells make it more effective against intracellular pathogens like *Mycoplasma pneumoniae*, *Chlamydia pneumoniae*, and *Legionella* species — a key reason it is preferred over erythromycin in community-acquired pneumonia.

### Why Erythromycin Is Rarely Used Now

**Mnemonic: ERYTHRO-PROBLEMS** — Erythromycin = Requires frequent dosing, Unstable in acid, Resistance emerging, Yeast overgrowth risk, Tolerability issues (GI side effects).

Erythromycin's poor acid stability necessitates either enteric-coated formulations or administration with food, and its short half-life demands QID dosing, making compliance difficult.

[cite:KD Tripathi 8e Ch 46]

Answer

A. Azithromycin is completely absorbed in the fasting state, whereas erythromycin requires food for absorption

Answer

B. Azithromycin has poor intracellular penetration and is restricted to extracellular pathogens

Answer

D. Azithromycin undergoes hepatic metabolism via CYP3A4, whereas erythromycin is renally excreted unchanged

A 32-year-old woman with community-acquired pneumonia is being treated with either erythromycin or azithromycin. Which pharmacokinetic property best differentiates azithromycin from erythromycin in clinical practice?

Explanation

Practice similar questions